Brief24Novo Nordisk sues Eli Lilly, alleging misleading GLP-1 advertising
CNBC·+9
qz.comNovo asked the court to permanently stop Lilly from running the "deceptive" ads and require the drugmaker to issue corrective advertising.
qz.comChat about this story
Quick actions
More coverage of this story
Quartz1 day ago
Novo Nordisk is suing Eli Lilly over ads it says mislead consumers on weight loss drug efficacy
Financial Times88 days ago
Novo Nordisk sues Eli Lilly over ‘deliberately false’ weight-loss drug ads
MarketWatch88 days ago
Novo Nordisk’s lawsuit against Eli Lilly over ads highlights intense competition in GLP-1 market
CBS88 days ago
Novo Nordisk sues Eli Lilly, accusing it of false advertising
NBC89 days ago